25 XP   0   0   10

Insulet Corporation
Buy, Hold or Sell?

Let's analyse Insulet together

PenkeI guess you are interested in Insulet Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Insulet Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Insulet Corporation

I send you an email if I find something interesting about Insulet Corporation.

Quick analysis of Insulet (30 sec.)










What can you expect buying and holding a share of Insulet? (30 sec.)

How much money do you get?

How much money do you get?
$0.47
When do you have the money?
1 year
How often do you get paid?
15.0%

What is your share worth?

Current worth
$10.46
Expected worth in 1 year
$14.12
How sure are you?
62.5%

+ What do you gain per year?

Total Gains per Share
$4.13
Return On Investment
2.6%

For what price can you sell your share?

Current Price per Share
$161.02
Expected price per share
$148.22 - $184.85
How sure are you?
50%

1. Valuation of Insulet (5 min.)




Live pricePrice per Share (EOD)

$161.02

Intrinsic Value Per Share

$-3.06 - $60.62

Total Value Per Share

$7.41 - $71.08

2. Growth of Insulet (5 min.)




Is Insulet growing?

Current yearPrevious yearGrowGrow %
How rich?$732.7m$443.3m$155.8m26.0%

How much money is Insulet making?

Current yearPrevious yearGrowGrow %
Making money$51.5m$1.1m$50.4m97.8%
Net Profit Margin11.4%0.2%--

How much money comes from the company's main activities?

3. Financial Health of Insulet (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#45 / 334

Most Revenue
#34 / 334

Most Profit
#25 / 334

What can you expect buying and holding a share of Insulet? (5 min.)

Welcome investor! Insulet's management wants to use your money to grow the business. In return you get a share of Insulet.

What can you expect buying and holding a share of Insulet?

First you should know what it really means to hold a share of Insulet. And how you can make/lose money.

Speculation

The Price per Share of Insulet is $161.02. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Insulet.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Insulet, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $10.46. Based on the TTM, the Book Value Change Per Share is $0.92 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.29 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.12 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Insulet.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps1.480.9%0.730.5%0.020.0%0.160.1%0.010.0%
Usd Book Value Change Per Share2.211.4%0.920.6%-0.29-0.2%0.370.2%0.220.1%
Usd Dividend Per Share0.150.1%0.120.1%0.010.0%0.040.0%0.020.0%
Usd Total Gains Per Share2.371.5%1.030.6%-0.28-0.2%0.410.3%0.230.1%
Usd Price Per Share216.98-245.94-252.03-224.02-137.41-
Price to Earnings Ratio36.77-128.35--102.60-254.78-86.44-
Price-to-Total Gains Ratio91.68-367.60-421.77-267.01-436.09-
Price to Book Ratio20.74-30.26-39.67-50.12-46.88-
Price-to-Total Gains Ratio91.68-367.60-421.77-267.01-436.09-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share161.02
Number of shares6
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.120.04
Usd Book Value Change Per Share0.920.37
Usd Total Gains Per Share1.030.41
Gains per Quarter (6 shares)6.192.44
Gains per Year (6 shares)24.759.76
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
132215190
26444021810
38666532720
411889033630
51411011544540
61713214055450
72015416566260
82217619077170
92519821588080
102822024088990

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%8.04.00.066.7%14.06.00.070.0%16.024.00.040.0%16.054.00.022.9%
Book Value Change Per Share4.00.00.0100.0%8.04.00.066.7%13.07.00.065.0%25.015.00.062.5%36.034.00.051.4%
Dividend per Share4.00.00.0100.0%6.00.06.050.0%6.00.014.030.0%6.00.034.015.0%6.00.064.08.6%
Total Gains per Share4.00.00.0100.0%8.04.00.066.7%13.07.00.065.0%25.015.00.062.5%36.034.00.051.4%

Fundamentals of Insulet

About Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Fundamental data was last updated by Penke on 2024-05-04 01:04:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Insulet Corporation.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Insulet earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Insulet to the Medical Devices industry mean.
  • A Net Profit Margin of 20.3% means that $0.20 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Insulet Corporation:

  • The MRQ is 20.3%. The company is making a huge profit. +2
  • The TTM is 11.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ20.3%TTM11.4%+8.8%
TTM11.4%YOY0.2%+11.2%
TTM11.4%5Y3.1%+8.4%
5Y3.1%10Y-3.9%+6.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ20.3%-11.2%+31.5%
TTM11.4%-17.5%+28.9%
YOY0.2%-13.2%+13.4%
5Y3.1%-19.6%+22.7%
10Y-3.9%-25.0%+21.1%
1.1.2. Return on Assets

Shows how efficient Insulet is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Insulet to the Medical Devices industry mean.
  • 4.0% Return on Assets means that Insulet generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Insulet Corporation:

  • The MRQ is 4.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.0%TTM2.1%+1.9%
TTM2.1%YOY0.1%+2.0%
TTM2.1%5Y0.5%+1.5%
5Y0.5%10Y-1.1%+1.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0%-4.0%+8.0%
TTM2.1%-4.2%+6.3%
YOY0.1%-4.1%+4.2%
5Y0.5%-3.7%+4.2%
10Y-1.1%-4.3%+3.2%
1.1.3. Return on Equity

Shows how efficient Insulet is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Insulet to the Medical Devices industry mean.
  • 14.1% Return on Equity means Insulet generated $0.14 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Insulet Corporation:

  • The MRQ is 14.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 8.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.1%TTM8.1%+6.0%
TTM8.1%YOY0.1%+8.0%
TTM8.1%5Y2.1%+5.9%
5Y2.1%10Y-7.2%+9.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ14.1%-3.9%+18.0%
TTM8.1%-5.0%+13.1%
YOY0.1%-4.8%+4.9%
5Y2.1%-5.6%+7.7%
10Y-7.2%-6.4%-0.8%

1.2. Operating Efficiency of Insulet Corporation.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Insulet is operating .

  • Measures how much profit Insulet makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Insulet to the Medical Devices industry mean.
  • An Operating Margin of 9.4% means the company generated $0.09  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Insulet Corporation:

  • The MRQ is 9.4%. The company is operating less efficient.
  • The TTM is 8.2%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ9.4%TTM8.2%+1.2%
TTM8.2%YOY-0.8%+9.0%
TTM8.2%5Y3.5%+4.7%
5Y3.5%10Y-1.5%+5.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ9.4%-28.0%+37.4%
TTM8.2%-14.7%+22.9%
YOY-0.8%-13.1%+12.3%
5Y3.5%-18.5%+22.0%
10Y-1.5%-24.8%+23.3%
1.2.2. Operating Ratio

Measures how efficient Insulet is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.79 means that the operating costs are $0.79 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Insulet Corporation:

  • The MRQ is 0.791. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.877. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.791TTM0.877-0.086
TTM0.877YOY0.972-0.095
TTM0.8775Y0.923-0.045
5Y0.92310Y0.984-0.061
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7911.429-0.638
TTM0.8771.425-0.548
YOY0.9721.389-0.417
5Y0.9231.419-0.496
10Y0.9841.376-0.392

1.3. Liquidity of Insulet Corporation.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Insulet is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.47 means the company has $3.47 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Insulet Corporation:

  • The MRQ is 3.471. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.386. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.471TTM3.386+0.085
TTM3.386YOY4.561-1.175
TTM3.3865Y5.015-1.629
5Y5.01510Y4.950+0.065
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4712.643+0.828
TTM3.3862.709+0.677
YOY4.5613.407+1.154
5Y5.0153.617+1.398
10Y4.9503.475+1.475
1.3.2. Quick Ratio

Measures if Insulet is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Insulet to the Medical Devices industry mean.
  • A Quick Ratio of 2.48 means the company can pay off $2.48 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Insulet Corporation:

  • The MRQ is 2.477. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.416. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.477TTM2.416+0.061
TTM2.416YOY3.276-0.860
TTM2.4165Y4.286-1.870
5Y4.28610Y4.915-0.629
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4771.521+0.956
TTM2.4161.666+0.750
YOY3.2762.107+1.169
5Y4.2862.308+1.978
10Y4.9152.419+2.496

1.4. Solvency of Insulet Corporation.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Insulet assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Insulet to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.72 means that Insulet assets are financed with 71.7% credit (debt) and the remaining percentage (100% - 71.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Insulet Corporation:

  • The MRQ is 0.717. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.755. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.717TTM0.755-0.038
TTM0.755YOY0.794-0.039
TTM0.7555Y0.769-0.014
5Y0.76910Y0.784-0.016
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7170.406+0.311
TTM0.7550.398+0.357
YOY0.7940.347+0.447
5Y0.7690.442+0.327
10Y0.7840.457+0.327
1.4.2. Debt to Equity Ratio

Measures if Insulet is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Insulet to the Medical Devices industry mean.
  • A Debt to Equity ratio of 253.2% means that company has $2.53 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Insulet Corporation:

  • The MRQ is 2.532. The company is unable to pay all its debts with equity. -1
  • The TTM is 3.114. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.532TTM3.114-0.581
TTM3.114YOY3.856-0.742
TTM3.1145Y4.511-1.397
5Y4.51110Y4.584-0.074
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5320.596+1.936
TTM3.1140.595+2.519
YOY3.8560.495+3.361
5Y4.5110.637+3.874
10Y4.5840.707+3.877

2. Market Valuation of Insulet Corporation

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Insulet generates.

  • Above 15 is considered overpriced but always compare Insulet to the Medical Devices industry mean.
  • A PE ratio of 36.77 means the investor is paying $36.77 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Insulet Corporation:

  • The EOD is 27.287. Based on the earnings, the company is overpriced. -1
  • The MRQ is 36.770. Based on the earnings, the company is overpriced. -1
  • The TTM is 128.348. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD27.287MRQ36.770-9.483
MRQ36.770TTM128.348-91.578
TTM128.348YOY-102.595+230.943
TTM128.3485Y254.785-126.437
5Y254.78510Y86.439+168.345
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD27.287-1.028+28.315
MRQ36.770-1.706+38.476
TTM128.348-2.264+130.612
YOY-102.595-2.813-99.782
5Y254.785-2.443+257.228
10Y86.439-2.020+88.459
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Insulet Corporation:

  • The EOD is 211.937. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 285.592. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 103.866. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD211.937MRQ285.592-73.655
MRQ285.592TTM103.866+181.726
TTM103.866YOY124.310-20.445
TTM103.8665Y60.462+43.403
5Y60.46210Y65.354-4.892
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD211.937-1.275+213.212
MRQ285.592-2.333+287.925
TTM103.866-2.994+106.860
YOY124.310-5.897+130.207
5Y60.462-5.314+65.776
10Y65.354-5.639+70.993
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Insulet is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 20.74 means the investor is paying $20.74 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Insulet Corporation:

  • The EOD is 15.388. Based on the equity, the company is expensive. -2
  • The MRQ is 20.736. Based on the equity, the company is expensive. -2
  • The TTM is 30.261. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD15.388MRQ20.736-5.348
MRQ20.736TTM30.261-9.525
TTM30.261YOY39.672-9.411
TTM30.2615Y50.122-19.861
5Y50.12210Y46.884+3.238
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD15.3882.024+13.364
MRQ20.7362.372+18.364
TTM30.2612.487+27.774
YOY39.6723.042+36.630
5Y50.1223.891+46.231
10Y46.8844.381+42.503
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Insulet Corporation.

3.1. Institutions holding Insulet Corporation

Institutions are holding 103.937% of the shares of Insulet Corporation.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Capital Research Global Investors13.53370.50599476623155645519.6518
2023-12-31Vanguard Group Inc11.46720.03818029608293870.3673
2023-12-31BlackRock Inc8.71510.033861025461058811.7657
2023-12-31FMR Inc8.38860.09795873891-704087-10.7037
2023-12-31Wellington Management Company LLP4.63580.131332461242115786.9723
2023-12-31State Street Corporation4.120.03052884915511511.8051
2023-12-31Capital World Investors3.15870.08542211778-161605-6.8091
2023-12-31Goldman Sachs Group Inc2.50930.034217570581195178212.7105
2023-12-31Geode Capital Management, LLC2.29840.03641609418412842.6327
2023-09-30Citadel Advisors Llc1.99910.047913998311094792358.9023
2023-12-31ClearBridge Advisors, LLC1.89630.24791327851-103029-7.2004
2023-12-31Baillie Gifford & Co Limited.1.7320.2085121275912127590
2023-12-31NORGES BANK1.49840.03981049200691595193.3963
2023-12-31Morgan Stanley - Brokerage Accounts1.44950.01941014975-28322-2.7147
2023-12-31D1 Capital Partners L.P.1.43523.83181004946-816000-44.8119
2023-12-31William Blair Investment Management, LLC1.3120.580191868918576625.3459
2023-12-31Amvescap Plc.1.06330.0384744569-100368-11.8788
2023-12-31Westfield Capital Management Company, LP1.00740.89217054296816810.697
2023-12-31Northern Trust Corp0.95190.0262666575-15156-2.2232
2023-12-31Ameriprise Financial Inc0.9350.0425654705-183859-21.9255
Total 74.10696.968151891490+4331568+8.3%

3.2. Funds holding Insulet Corporation

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Capital Group Growth Fnd of Amer Comp4.41250.2692308975164164626.2099
2023-12-31Capital Group AMCAP Composite4.24410.8026297181161020925.8388
2024-03-31Vanguard Total Stock Mkt Idx Inv3.13380.0235219437776710.3508
2024-03-31VA CollegeAmerica Amcap 529A2.99940.39512100230-871581-29.3283
2024-03-31American Funds Growth Fund of Amer A2.8530.11881997736-1092015-35.3431
2024-03-31Vanguard Institutional 500 Index Trust2.51440.02711760619168080.9639
2023-12-31Vanguard Health Care Inv2.08090.6812145711200
2024-02-29Fidelity OTC2.07530.8367145316914180010.8131
2023-12-31Capital Group New Perspective Comp1.75950.211123202300
2023-12-31Capital Group World Growth & Inc Cmp1.50060.19391050746-171870-14.0576
2024-03-31American Funds Capital World Gr&Inc A1.44410.13271011179-39567-3.7656
2024-03-31American Funds New Economy A1.43410.48711004180898249.8237
2024-03-31American Funds SMALLCAP World A1.3760.2116963534-406261-29.6585
2023-12-31Capital Group New Economy Comp1.30580.645191435612153715.3297
2024-03-31Vanguard Small Cap Index1.27210.10378907498907490
2024-03-31SPDR® S&P 500 ETF Trust1.20330.0271842568-6478-0.763
2024-02-29Fidelity 500 Index1.1960.026783747984271.0165
2024-03-31Vanguard Mid Cap Index Institutional1.0830.078758325-802051-51.4011
2024-02-29Fidelity Select Medical Tech and Devcs1.03972.035572800000
2024-03-28iShares Core S&P 500 ETF1.03410.027172412653760.748
Total 39.96177.333727982070-855776-3.1%

3.3. Insider Transactions

Insiders are holding 0.31% of the shares of Insulet Corporation.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-28Shacey PetrovicSELL11609162.92
2023-11-13Shacey PetrovicSELL20000164.33
2023-09-19Prem SinghBUY1168.92
2023-08-28James HollingsheadBUY5550181.41
2023-07-03Wayde D McmillanSELL1388282.94
2023-06-20Dan ManeaSELL175290
2023-06-05Luciana BorioSELL500283.38
2023-06-01Shacey PetrovicSELL15000271.56

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Insulet Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--2.2120.915+142%-0.285+113%0.372+495%0.217+919%
Book Value Per Share--10.4648.446+24%6.332+65%6.254+67%3.808+175%
Current Ratio--3.4713.386+3%4.561-24%5.015-31%4.950-30%
Debt To Asset Ratio--0.7170.755-5%0.794-10%0.769-7%0.784-9%
Debt To Equity Ratio--2.5323.114-19%3.856-34%4.511-44%4.584-45%
Dividend Per Share--0.1540.116+33%0.008+1864%0.035+339%0.018+779%
Eps--1.4750.727+103%0.016+8883%0.156+846%0.015+9965%
Free Cash Flow Per Share--0.1900.123+54%-0.137+172%-0.250+231%-0.194+202%
Free Cash Flow To Equity Per Share--0.2260.077+193%-0.281+224%0.2260%0.214+6%
Gross Profit Margin--1.0001.0000%1.0000%-4.451+545%-0.343+134%
Intrinsic Value_10Y_max--60.615--------
Intrinsic Value_10Y_min---3.056--------
Intrinsic Value_1Y_max--0.215--------
Intrinsic Value_1Y_min---0.826--------
Intrinsic Value_3Y_max--5.112--------
Intrinsic Value_3Y_min---2.047--------
Intrinsic Value_5Y_max--15.391--------
Intrinsic Value_5Y_min---2.780--------
Market Cap11275022305.920-35%15193481182.08017379584345.520-13%17647769666.880-14%15717984856.032-3%9637922691.708+58%
Net Profit Margin--0.2030.114+77%0.002+10115%0.031+564%-0.039+119%
Operating Margin--0.0940.082+15%-0.008+108%0.035+166%-0.015+116%
Operating Ratio--0.7910.877-10%0.972-19%0.923-14%0.984-20%
Pb Ratio15.388-35%20.73630.261-31%39.672-48%50.122-59%46.884-56%
Pe Ratio27.287-35%36.770128.348-71%-102.595+379%254.785-86%86.439-57%
Price Per Share161.020-35%216.980245.943-12%252.030-14%224.019-3%137.415+58%
Price To Free Cash Flow Ratio211.937-35%285.592103.866+175%124.310+130%60.462+372%65.354+337%
Price To Total Gains Ratio68.038-35%91.683367.597-75%421.770-78%267.014-66%436.086-79%
Quick Ratio--2.4772.416+3%3.276-24%4.286-42%4.915-50%
Return On Assets--0.0400.021+93%0.001+7773%0.005+637%-0.011+128%
Return On Equity--0.1410.081+75%0.001+19286%0.021+559%-0.072+151%
Total Gains Per Share--2.3671.031+129%-0.277+112%0.407+482%0.235+909%
Usd Book Value--732700000.000599225000.000+22%443375000.000+65%439488900.000+67%267435325.000+174%
Usd Book Value Change Per Share--2.2120.915+142%-0.285+113%0.372+495%0.217+919%
Usd Book Value Per Share--10.4648.446+24%6.332+65%6.254+67%3.808+175%
Usd Dividend Per Share--0.1540.116+33%0.008+1864%0.035+339%0.018+779%
Usd Eps--1.4750.727+103%0.016+8883%0.156+846%0.015+9965%
Usd Free Cash Flow--13300000.0009050000.000+47%-9575000.000+172%-17395000.000+231%-13557600.000+202%
Usd Free Cash Flow Per Share--0.1900.123+54%-0.137+172%-0.250+231%-0.194+202%
Usd Free Cash Flow To Equity Per Share--0.2260.077+193%-0.281+224%0.2260%0.214+6%
Usd Market Cap11275022305.920-35%15193481182.08017379584345.520-13%17647769666.880-14%15717984856.032-3%9637922691.708+58%
Usd Price Per Share161.020-35%216.980245.943-12%252.030-14%224.019-3%137.415+58%
Usd Profit--103300000.00051575000.000+100%1150000.000+8883%12336600.000+737%1732350.000+5863%
Usd Revenue--509800000.000424275000.000+20%326325000.000+56%287190300.000+78%193783275.000+163%
Usd Total Gains Per Share--2.3671.031+129%-0.277+112%0.407+482%0.235+909%
 EOD+4 -4MRQTTM+30 -5YOY+27 -85Y+27 -910Y+31 -5

4.2. Fundamental Score

Let's check the fundamental score of Insulet Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1527.287
Price to Book Ratio (EOD)Between0-115.388
Net Profit Margin (MRQ)Greater than00.203
Operating Margin (MRQ)Greater than00.094
Quick Ratio (MRQ)Greater than12.477
Current Ratio (MRQ)Greater than13.471
Debt to Asset Ratio (MRQ)Less than10.717
Debt to Equity Ratio (MRQ)Less than12.532
Return on Equity (MRQ)Greater than0.150.141
Return on Assets (MRQ)Greater than0.050.040
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Insulet Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.858
Ma 20Greater thanMa 50170.014
Ma 50Greater thanMa 100170.314
Ma 100Greater thanMa 200183.918
OpenGreater thanClose166.000
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income Tax Expense  5,300-4,5008004001,2006001,800-13,900-12,100



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets2,588,200
Total Liabilities1,855,500
Total Stockholder Equity732,700
 As reported
Total Liabilities 1,855,500
Total Stockholder Equity+ 732,700
Total Assets = 2,588,200

Assets

Total Assets2,588,200
Total Current Assets1,566,300
Long-term Assets1,021,900
Total Current Assets
Cash And Cash Equivalents 650,700
Short-term Investments 53,500
Net Receivables 359,700
Inventory 402,600
Other Current Assets 99,800
Total Current Assets  (as reported)1,566,300
Total Current Assets  (calculated)1,566,300
+/-0
Long-term Assets
Property Plant Equipment 692,800
Goodwill 51,700
Intangible Assets 98,700
Long-term Assets Other 178,700
Long-term Assets  (as reported)1,021,900
Long-term Assets  (calculated)1,021,900
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities451,200
Long-term Liabilities1,404,300
Total Stockholder Equity732,700
Total Current Liabilities
Short-term Debt 52,900
Short Long Term Debt 49,400
Accounts payable 19,200
Other Current Liabilities 363,700
Total Current Liabilities  (as reported)451,200
Total Current Liabilities  (calculated)485,200
+/- 34,000
Long-term Liabilities
Long term Debt 1,366,400
Long-term Liabilities Other 37,900
Long-term Liabilities  (as reported)1,404,300
Long-term Liabilities  (calculated)1,404,300
+/-0
Total Stockholder Equity
Common Stock100
Retained Earnings -378,000
Accumulated Other Comprehensive Income 8,000
Other Stockholders Equity 1,102,600
Total Stockholder Equity (as reported)732,700
Total Stockholder Equity (calculated)732,700
+/-0
Other
Capital Stock100
Cash and Short Term Investments 704,200
Common Stock Shares Outstanding 69,860
Current Deferred Revenue15,400
Liabilities and Stockholders Equity 2,588,200
Net Debt 798,100
Net Invested Capital 2,148,500
Net Working Capital 1,131,700
Property Plant and Equipment Gross 958,100
Short Long Term Debt Total 1,448,800



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-31
> Total Assets 
0
0
0
16,792
0
0
44,907
57,140
47,682
149,140
135,605
130,741
116,467
154,573
135,332
109,229
119,852
99,313
117,128
171,648
159,037
161,990
149,854
156,233
148,926
226,190
215,780
209,583
203,942
191,940
191,642
198,059
280,899
286,152
289,496
287,955
288,528
325,328
301,197
302,156
305,716
300,393
293,120
275,126
254,774
263,045
453,197
456,647
444,957
459,327
500,348
816,744
829,763
838,856
886,306
928,744
952,612
977,723
1,268,390
1,142,900
1,108,200
1,626,700
1,710,600
1,872,900
1,840,100
1,923,700
1,998,900
2,048,800
2,069,200
2,113,700
2,166,200
2,251,100
2,289,100
2,385,800
2,467,700
2,588,200
2,588,2002,467,7002,385,8002,289,1002,251,1002,166,2002,113,7002,069,2002,048,8001,998,9001,923,7001,840,1001,872,9001,710,6001,626,7001,108,2001,142,9001,268,390977,723952,612928,744886,306838,856829,763816,744500,348459,327444,957456,647453,197263,045254,774275,126293,120300,393305,716302,156301,197325,328288,528287,955289,496286,152280,899198,059191,642191,940203,942209,583215,780226,190148,926156,233149,854161,990159,037171,648117,12899,313119,852109,229135,332154,573116,467130,741135,605149,14047,68257,14044,9070016,792000
   > Total Current Assets 
0
0
0
9,683
0
0
29,171
39,865
27,247
127,828
113,891
108,752
90,607
124,952
105,964
88,499
99,987
80,380
99,791
154,304
142,173
145,602
133,328
142,457
133,537
147,834
137,857
131,785
127,369
115,615
113,394
109,936
194,757
197,129
199,686
198,198
199,857
231,832
206,613
208,196
205,427
203,829
194,338
190,761
171,845
181,290
361,807
369,960
337,168
338,745
366,020
537,171
451,611
421,793
445,712
461,286
496,382
498,807
793,901
591,000
541,300
1,085,700
1,160,400
1,248,700
1,191,800
1,252,900
1,306,900
1,329,800
1,285,400
1,309,100
1,329,100
1,314,000
1,330,000
1,421,500
1,471,100
1,566,300
1,566,3001,471,1001,421,5001,330,0001,314,0001,329,1001,309,1001,285,4001,329,8001,306,9001,252,9001,191,8001,248,7001,160,4001,085,700541,300591,000793,901498,807496,382461,286445,712421,793451,611537,171366,020338,745337,168369,960361,807181,290171,845190,761194,338203,829205,427208,196206,613231,832199,857198,198199,686197,129194,757109,936113,394115,615127,369131,785137,857147,834133,537142,457133,328145,602142,173154,30499,79180,38099,98788,499105,964124,95290,607108,752113,891127,82827,24739,86529,171009,683000
       Cash And Cash Equivalents 
0
0
0
7,660
0
0
25,090
33,231
19,076
119,818
104,213
94,588
73,035
99,108
74,134
56,663
68,164
52,362
72,694
127,996
118,338
118,071
103,918
113,274
104,488
106,746
103,812
93,955
83,006
70,144
63,443
57,293
148,065
150,944
153,905
149,727
145,614
175,545
146,372
151,193
145,608
145,137
145,467
122,672
111,635
111,266
215,402
298,570
76,038
258,605
275,756
440,056
203,146
136,246
126,563
288,946
129,254
309,748
605,504
376,100
321,600
844,400
896,700
947,600
850,200
872,100
857,100
791,600
709,600
708,600
722,000
674,700
620,700
660,100
685,400
650,700
650,700685,400660,100620,700674,700722,000708,600709,600791,600857,100872,100850,200947,600896,700844,400321,600376,100605,504309,748129,254288,946126,563136,246203,146440,056275,756258,60576,038298,570215,402111,266111,635122,672145,467145,137145,608151,193146,372175,545145,614149,727153,905150,944148,06557,29363,44370,14483,00693,955103,812106,746104,488113,274103,918118,071118,338127,99672,69452,36268,16456,66374,13499,10873,03594,588104,213119,81819,07633,23125,090007,660000
       Short-term Investments 
0
0
0
550
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,605
67,293
161,396
177,990
185,117
173,523
167,479
148,853
163,546
163,281
175,040
187,120
189,881
185,622
162,400
120,200
65,300
58,600
40,400
29,500
17,500
500
0
0
50,000
50,400
50,800
102,000
103,300
104,700
53,500
53,500104,700103,300102,00050,80050,40050,0000050017,50029,50040,40058,60065,300120,200162,400185,622189,881187,120175,040163,281163,546148,853167,479173,523185,117177,990161,39667,29335,60500000000000000000000000000000000000000000550000
       Net Receivables 
0
0
0
140
0
0
1,002
1,417
2,118
2,633
3,343
4,783
7,223
9,760
11,842
11,938
13,291
15,509
16,357
14,962
15,206
15,801
15,442
16,841
15,009
20,361
17,269
23,190
26,197
25,591
30,145
33,294
31,110
33,650
34,465
33,067
36,679
41,797
47,145
39,882
36,093
31,826
31,803
42,530
40,474
38,700
38,548
28,803
40,648
37,753
47,173
53,373
55,829
63,634
79,913
76,672
78,158
78,739
77,537
82,800
80,100
78,000
85,400
83,800
97,900
100,300
114,300
161,000
189,300
206,600
201,400
205,600
217,200
250,500
270,300
359,700
359,700270,300250,500217,200205,600201,400206,600189,300161,000114,300100,30097,90083,80085,40078,00080,10082,80077,53778,73978,15876,67279,91363,63455,82953,37347,17337,75340,64828,80338,54838,70040,47442,53031,80331,82636,09339,88247,14541,79736,67933,06734,46533,65031,11033,29430,14525,59126,19723,19017,26920,36115,00916,84115,44215,80115,20614,96216,35715,50913,29111,93811,8429,7607,2234,7833,3432,6332,1181,4171,00200140000
       Other Current Assets 
0
0
0
1,019
0
0
834
1,827
1,797
1,248
1,763
1,391
2,843
2,748
3,521
3,028
3,385
2,100
1,565
1,260
2,029
1,499
1,059
912
1,841
4,770
3,653
2,802
3,463
3,454
4,717
4,482
6,383
6,556
5,921
5,940
7,115
5,725
3,434
4,022
3,661
3,431
4,049
4,283
5,712
6,838
7,901
7,073
8,159
8,431
8,037
9,949
17,449
17,559
17,905
24,254
28,028
25,211
20,653
31,100
43,900
59,600
53,400
63,000
73,600
82,700
76,500
74,000
71,700
73,500
78,100
86,900
106,000
99,600
104,600
99,800
99,800104,60099,600106,00086,90078,10073,50071,70074,00076,50082,70073,60063,00053,40059,60043,90031,10020,65325,21128,02824,25417,90517,55917,4499,9498,0378,4318,1597,0737,9016,8385,7124,2834,0493,4313,6614,0223,4345,7257,1155,9405,9216,5566,3834,4824,7173,4543,4632,8023,6534,7701,8419121,0591,4992,0291,2601,5652,1003,3853,0283,5212,7482,8431,3911,7631,2481,7971,827834001,019000
   > Long-term Assets 
0
0
0
7,109
0
0
15,736
17,275
20,435
21,312
21,714
21,989
25,860
29,621
29,368
20,730
19,865
18,933
17,337
17,344
16,864
16,388
16,526
13,776
15,389
78,356
77,923
77,798
76,573
76,325
78,248
88,123
86,142
89,023
89,810
89,757
88,671
93,496
94,584
93,960
100,289
96,564
98,782
84,365
82,929
81,755
91,390
86,687
107,789
120,582
134,328
279,573
378,152
417,063
440,594
467,458
456,230
478,916
474,489
551,900
566,900
541,000
550,200
624,200
648,300
670,800
692,000
719,000
783,800
804,600
837,100
937,100
959,100
964,300
996,600
1,021,900
1,021,900996,600964,300959,100937,100837,100804,600783,800719,000692,000670,800648,300624,200550,200541,000566,900551,900474,489478,916456,230467,458440,594417,063378,152279,573134,328120,582107,78986,68791,39081,75582,92984,36598,78296,564100,28993,96094,58493,49688,67189,75789,81089,02386,14288,12378,24876,32576,57377,79877,92378,35615,38913,77616,52616,38816,86417,34417,33718,93319,86520,73029,36829,62125,86021,98921,71421,31220,43517,27515,736007,109000
       Property Plant Equipment 
0
0
0
7,054
0
0
15,682
16,999
18,484
20,490
20,960
21,304
25,225
26,244
26,080
17,564
16,423
15,689
15,531
15,482
15,134
13,751
14,147
12,522
14,256
16,125
18,295
19,422
19,947
21,422
24,910
25,422
24,982
29,334
31,399
32,356
32,556
34,159
36,582
37,069
44,612
42,040
41,536
41,793
41,695
41,131
50,911
46,266
65,279
75,878
88,491
107,864
153,029
197,564
229,433
258,379
307,891
334,025
355,865
399,400
412,400
423,200
449,200
478,700
497,900
505,500
515,400
536,500
538,200
535,800
553,100
599,900
596,600
601,500
649,200
692,800
692,800649,200601,500596,600599,900553,100535,800538,200536,500515,400505,500497,900478,700449,200423,200412,400399,400355,865334,025307,891258,379229,433197,564153,029107,86488,49175,87865,27946,26650,91141,13141,69541,79341,53642,04044,61237,06936,58234,15932,55632,35631,39929,33424,98225,42224,91021,42219,94719,42218,29516,12514,25612,52214,14713,75115,13415,48215,53115,68916,42317,56426,08026,24425,22521,30420,96020,49018,48416,99915,682007,054000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,727
26,164
26,647
26,647
26,647
26,647
37,536
37,536
37,536
37,536
37,536
37,536
37,536
37,536
37,536
37,536
37,536
39,823
39,607
39,761
39,763
39,730
39,677
39,697
39,759
39,854
39,840
39,773
39,731
39,774
39,646
39,694
39,739
39,713
39,800
39,600
39,600
39,700
39,800
39,800
39,900
39,800
39,800
51,800
51,800
51,600
51,700
51,700
51,700
51,700
51,700
51,70051,70051,70051,70051,70051,60051,80051,80039,80039,80039,90039,80039,80039,70039,60039,60039,80039,71339,73939,69439,64639,77439,73139,77339,84039,85439,75939,69739,67739,73039,76339,76139,60739,82337,53637,53637,53637,53637,53637,53637,53637,53637,53637,53637,53626,64726,64726,64726,64726,16426,7270000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
125,549
164,117
156,060
145,539
140,784
76,789
62,677
31,006
58,400
60,800
23,500
500
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000050023,50060,80058,40031,00662,67776,789140,784145,539156,060164,117125,549000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,401
30,673
29,002
27,332
25,753
24,358
22,963
21,568
20,267
19,154
18,040
16,927
15,882
14,973
14,064
13,155
12,301
13,039
933
885
773
651
528
2,208
3,386
4,369
4,351
4,570
5,747
7,791
10,383
11,484
13,040
12,834
13,200
12,400
10,900
10,400
28,700
29,700
33,400
37,200
36,600
52,800
55,100
53,700
75,500
100,200
99,500
99,500
98,700
98,70099,50099,500100,20075,50053,70055,10052,80036,60037,20033,40029,70028,70010,40010,90012,40013,20012,83413,04011,48410,3837,7915,7474,5704,3514,3693,3862,20852865177388593313,03912,30113,15514,06414,97315,88216,92718,04019,15420,26721,56822,96324,35825,75327,33229,00230,67332,4010000000000000000000000000
       Other Assets 
0
0
0
55
0
0
0
276
1,951
822
754
685
635
3,377
3,288
3,166
3,442
3,244
3,097
3,072
2,855
2,637
2,379
1,254
1,133
73,570
70,967
69,265
67,515
65,792
64,227
62,701
61,160
59,689
58,411
57,401
56,115
59,337
58,002
56,891
55,677
54,524
57,246
42,572
41,234
40,624
40,479
40,421
42,510
44,704
45,837
171,709
16,663
17,961
18,057
18,266
20,372
21,415
22,881
25,000
41,700
43,800
50,400
79,000
80,900
92,000
99,600
106,100
118,400
134,800
178,700
147,100
179,600
177,600
0
0
00177,600179,600147,100178,700134,800118,400106,10099,60092,00080,90079,00050,40043,80041,70025,00022,88121,41520,37218,26618,05717,96116,663171,70945,83744,70442,51040,42140,47940,62441,23442,57257,24654,52455,67756,89158,00259,33756,11557,40158,41159,68961,16062,70164,22765,79267,51569,26570,96773,5701,1331,2542,3792,6372,8553,0723,0973,2443,4423,1663,2883,3776356857548221,95127600055000
> Total Liabilities 
0
0
0
82,883
0
0
135,823
158,905
160,757
39,620
39,307
38,466
42,828
103,282
103,684
104,955
104,395
102,784
116,825
118,791
118,113
118,009
116,349
90,002
89,146
132,091
132,340
138,187
145,064
144,190
152,529
153,883
151,352
147,817
168,070
163,358
166,036
247,444
220,857
218,327
224,974
230,138
237,987
241,075
228,378
235,601
388,102
393,497
381,372
394,602
426,094
658,228
659,195
659,708
688,377
716,645
728,982
727,943
1,117,822
1,067,000
1,049,200
1,063,400
1,115,600
1,269,300
1,254,800
1,464,600
1,501,000
1,492,500
1,622,500
1,691,300
1,738,200
1,774,700
1,786,300
1,831,900
1,860,200
1,855,500
1,855,5001,860,2001,831,9001,786,3001,774,7001,738,2001,691,3001,622,5001,492,5001,501,0001,464,6001,254,8001,269,3001,115,6001,063,4001,049,2001,067,0001,117,822727,943728,982716,645688,377659,708659,195658,228426,094394,602381,372393,497388,102235,601228,378241,075237,987230,138224,974218,327220,857247,444166,036163,358168,070147,817151,352153,883152,529144,190145,064138,187132,340132,09189,14690,002116,349118,009118,113118,791116,825102,784104,395104,955103,684103,28242,82838,46639,30739,620160,757158,905135,8230082,883000
   > Total Current Liabilities 
0
0
0
4,515
0
0
9,237
39,080
40,931
17,045
19,306
21,029
25,944
15,534
15,823
16,968
19,790
16,783
18,217
19,813
17,932
23,760
20,442
18,950
16,797
26,611
24,761
27,995
32,580
43,140
49,342
48,286
42,980
33,853
48,294
42,374
43,118
71,199
47,764
44,296
47,376
52,682
59,437
65,156
49,775
55,181
54,252
55,697
39,379
48,018
74,940
86,025
82,414
76,109
97,224
115,657
113,973
105,773
113,282
157,700
130,400
134,400
175,200
207,800
185,500
213,300
228,600
228,800
215,000
279,300
334,200
364,700
383,300
425,000
451,400
451,200
451,200451,400425,000383,300364,700334,200279,300215,000228,800228,600213,300185,500207,800175,200134,400130,400157,700113,282105,773113,973115,65797,22476,10982,41486,02574,94048,01839,37955,69754,25255,18149,77565,15659,43752,68247,37644,29647,76471,19943,11842,37448,29433,85342,98048,28649,34243,14032,58027,99524,76126,61116,79718,95020,44223,76017,93219,81318,21716,78319,79016,96815,82315,53425,94421,02919,30617,04540,93139,0809,237004,515000
       Short-term Debt 
0
0
0
1,479
0
0
2,648
29,222
29,225
7,943
10,671
10,671
10,670
0
0
0
0
0
0
0
0
0
0
0
0
12,276
12,762
13,064
12,916
13,849
14,134
14,429
14,733
1,236
2,593
2,637
2,752
26,746
3,990
3,380
5,996
6,235
6,020
5,519
4,447
2,315
1,061
269
0
340,836
344,953
566,173
42,308
577,119
0
0
2,315
0
0
0
0
3,900
4,600
15,600
15,700
20,900
28,900
25,100
25,700
26,300
26,900
27,500
27,800
29,200
49,800
52,900
52,90049,80029,20027,80027,50026,90026,30025,70025,10028,90020,90015,70015,6004,6003,90000002,31500577,11942,308566,173344,953340,83602691,0612,3154,4475,5196,0206,2355,9963,3803,99026,7462,7522,6372,5931,23614,73314,42914,13413,84912,91613,06412,76212,27600000000000010,67010,67110,6717,94329,22529,2222,648001,479000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
169,663
0
0
0
177,486
4,447
2,315
1,061
332,768
0
340,836
344,953
566,173
3,451
577,119
0
0
2,315
0
0
0
0
0
0
15,600
15,700
20,900
28,900
25,100
25,700
26,300
26,900
27,500
27,800
29,200
49,800
49,400
49,40049,80029,20027,80027,50026,90026,30025,70025,10028,90020,90015,70015,6000000002,31500577,1193,451566,173344,953340,8360332,7681,0612,3154,447177,486000169,663000000000000000000000000000000000000000
       Accounts payable 
0
0
0
1,624
0
0
3,575
3,450
4,687
5,485
4,152
4,544
7,399
5,984
5,965
7,291
5,979
5,580
5,183
5,870
3,277
9,128
5,154
4,895
6,213
9,369
8,604
11,418
16,107
13,687
16,216
9,361
8,544
11,441
15,117
19,359
20,983
18,610
17,726
14,659
14,246
17,916
15,614
15,213
13,482
21,605
18,212
13,160
6,413
12,243
28,648
24,413
33,846
25,191
26,845
25,500
26,833
24,752
21,245
54,500
36,400
35,600
57,000
54,100
59,100
49,300
58,000
37,700
52,200
57,200
62,100
30,800
85,900
107,500
77,800
19,200
19,20077,800107,50085,90030,80062,10057,20052,20037,70058,00049,30059,10054,10057,00035,60036,40054,50021,24524,75226,83325,50026,84525,19133,84624,41328,64812,2436,41313,16018,21221,60513,48215,21315,61417,91614,24614,65917,72618,61020,98319,35915,11711,4418,5449,36116,21613,68716,10711,4188,6049,3696,2134,8955,1549,1283,2775,8705,1835,5805,9797,2915,9655,9847,3994,5444,1525,4854,6873,4503,575001,624000
       Other Current Liabilities 
0
0
0
1,296
0
0
2,826
6,124
6,340
2,854
3,772
4,464
6,538
7,869
7,587
7,300
11,327
8,153
9,623
9,973
10,128
9,814
11,462
9,808
8,742
1,241
1,202
931
926
14,456
17,854
19,051
18,042
20,276
30,017
19,478
18,771
24,588
25,214
24,703
25,267
26,443
35,547
42,063
30,385
29,938
33,732
40,959
31,839
34,648
44,897
59,256
3,451
48,580
68,169
88,973
85,945
81,021
92,037
103,200
94,000
89,900
109,300
133,100
104,800
138,100
137,300
166,000
137,100
192,500
241,700
290,300
247,400
268,900
310,000
363,700
363,700310,000268,900247,400290,300241,700192,500137,100166,000137,300138,100104,800133,100109,30089,90094,000103,20092,03781,02185,94588,97368,16948,5803,45159,25644,89734,64831,83940,95933,73229,93830,38542,06335,54726,44325,26724,70325,21424,58818,77119,47830,01720,27618,04219,05117,85414,4569269311,2021,2418,7429,80811,4629,81410,1289,9739,6238,15311,3277,3007,5877,8696,5384,4643,7722,8546,3406,1242,826001,296000
   > Long-term Liabilities 
0
0
0
78,368
0
0
126,586
119,825
119,826
22,575
20,001
17,437
16,884
87,748
87,861
87,987
84,605
86,001
98,608
98,978
100,181
94,249
95,907
71,052
72,349
105,480
107,579
110,192
112,484
101,050
103,187
105,597
108,372
113,964
119,776
120,984
122,918
176,245
173,093
174,031
177,598
177,456
178,550
175,919
178,603
180,420
333,850
337,800
341,993
346,584
351,154
572,203
576,781
583,599
591,153
600,988
615,009
622,170
1,004,540
909,300
918,800
929,000
940,400
1,061,500
1,069,300
1,251,300
1,272,400
1,263,700
1,407,500
1,412,000
1,404,000
1,410,000
1,403,000
1,406,900
1,408,800
1,404,300
1,404,3001,408,8001,406,9001,403,0001,410,0001,404,0001,412,0001,407,5001,263,7001,272,4001,251,3001,069,3001,061,500940,400929,000918,800909,3001,004,540622,170615,009600,988591,153583,599576,781572,203351,154346,584341,993337,800333,850180,420178,603175,919178,550177,456177,598174,031173,093176,245122,918120,984119,776113,964108,372105,597103,187101,050112,484110,192107,579105,48072,34971,05295,90794,249100,18198,97898,60886,00184,60587,98787,86187,74816,88417,43720,00122,575119,826119,825126,5860078,368000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
108,540
110,844
99,382
101,517
103,730
106,186
111,718
117,209
119,041
120,934
169,763
170,513
171,257
174,560
174,535
174,931
171,967
173,681
175,690
328,962
332,768
336,762
340,836
344,953
566,173
569,877
577,119
584,485
591,978
599,601
607,351
985,771
887,900
899,000
910,200
921,500
1,043,700
1,051,600
1,235,200
1,257,000
1,248,800
1,390,500
1,385,200
1,379,800
1,374,300
1,368,800
1,368,600
0
0
001,368,6001,368,8001,374,3001,379,8001,385,2001,390,5001,248,8001,257,0001,235,2001,051,6001,043,700921,500910,200899,000887,900985,771607,351599,601591,978584,485577,119569,877566,173344,953340,836336,762332,768328,962175,690173,681171,967174,931174,535174,560171,257170,513169,763120,934119,041117,209111,718106,186103,730101,51799,382110,844108,540000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,961
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000004,9610000000000000000000000000000000000000
       Other Liabilities 
0
0
0
566
0
0
0
316
317
1,234
1,328
1,431
3,546
2,748
2,861
2,987
3,159
2,922
2,706
1,999
1,964
1,957
1,728
1,619
1,492
2,524
2,481
2,052
2,040
2,068
2,070
1,167
1,486
1,546
1,767
1,943
1,984
1,521
2,580
2,774
3,038
2,921
3,619
3,952
4,922
4,730
4,888
5,032
5,231
5,748
6,201
6,030
6,904
6,480
6,668
9,010
7,529
7,323
7,219
7,000
19,800
18,800
18,900
17,800
17,700
16,100
15,400
14,900
17,000
26,800
24,200
8,300
0
38,300
0
0
0038,30008,30024,20026,80017,00014,90015,40016,10017,70017,80018,90018,80019,8007,0007,2197,3237,5299,0106,6686,4806,9046,0306,2015,7485,2315,0324,8884,7304,9223,9523,6192,9213,0382,7742,5801,5211,9841,9431,7671,5461,4861,1672,0702,0682,0402,0522,4812,5241,4921,6191,7281,9571,9641,9992,7062,9223,1592,9872,8612,7483,5461,4311,3281,234317316000566000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,442
15,475
15,570
15,988
17,211
18,183
19,282
19,900
20,600
19,700
20,700
21,900
22,800
24,400
24,300
26,100
26,600
27,800
28,200
31,300
33,000
33,100
0
0
0033,10033,00031,30028,20027,80026,60026,10024,30024,40022,80021,90020,70019,70020,60019,90019,28218,18317,21115,98815,57015,47514,4420000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
-66,091
0
0
-90,916
-101,765
-113,075
109,520
96,298
92,275
73,639
51,291
31,648
4,274
15,457
-3,471
303
52,857
40,924
43,981
33,505
66,231
59,780
94,099
83,440
71,396
58,878
47,750
39,113
44,176
129,547
138,335
121,426
124,597
122,492
77,884
80,340
83,829
80,742
70,255
55,133
34,051
26,396
27,444
65,095
63,150
63,585
64,725
74,254
158,516
170,568
179,148
197,929
212,099
223,630
249,780
150,568
75,900
59,000
563,300
595,000
603,600
585,300
459,100
497,900
556,300
446,700
422,400
428,000
476,400
502,800
553,900
607,500
732,700
732,700607,500553,900502,800476,400428,000422,400446,700556,300497,900459,100585,300603,600595,000563,30059,00075,900150,568249,780223,630212,099197,929179,148170,568158,51674,25464,72563,58563,15065,09527,44426,39634,05155,13370,25580,74283,82980,34077,884122,492124,597121,426138,335129,54744,17639,11347,75058,87871,39683,44094,09959,78066,23133,50543,98140,92452,857303-3,47115,4574,27431,64851,29173,63992,27596,298109,520-113,075-101,765-90,91600-66,091000
   Common Stock
0
0
0
1
0
0
1
1
-2,015
27
27
28
28
28
29
29
29
29
32
39
39
41
41
45
46
47
47
48
48
48
48
48
53
54
55
55
55
55
56
56
57
57
57
57
57
57
57
57
58
58
58
58
59
59
59
59
60
60
62
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
1001001001001001001001001001001001001001001001001006260605959595958585858575757575757575756565555555554534848484848474746454141393932292929292828282727-2,01511001000
   Retained Earnings Total Equity00-533,200-560,500-584,300-601,300-596,100-561,100-649,500-678,700-691,300-666,300-666,300-649,200-660,800-675,200-672,000-676,982-677,834-679,236-683,614-693,507-695,166-693,475-707,255-700,395-698,168-690,401-680,424-671,305-668,224-664,026-651,545-624,218-605,291-589,859-578,025-572,625-561,780-532,669-526,525-524,025-502,735-492,216-481,551-471,357-458,940-444,464-429,684-426,684-413,1220000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-62
0
0
-19
-19
-4,862
-4,862
-4,862
-9
-7,311
-7,311
-7,311
-8,323
-8,323
0
0
-13,545
-13,545
0
0
-18,368
-18,368
0
0
-22,933
0
0
0
-27,927
0
0
0
-34,462
0
0
0
-22,916
0
0
-467
-654
-254
-243
-387
-726
-657
-529
-123
-493
-1,536
-2,386
-2,452
-2,905
-3,085
-2,829
-4,652
-1,200
-3,800
-3,600
-600
5,500
3,200
700
-3,400
-2,200
12,200
7,200
6,800
20,000
15,900
16,300
7,600
8,000
8,0007,60016,30015,90020,0006,8007,20012,200-2,200-3,4007003,2005,500-600-3,600-3,800-1,200-4,652-2,829-3,085-2,905-2,452-2,386-1,536-493-123-529-657-726-387-243-254-654-46700-22,916000-34,462000-27,927000-22,93300-18,368-18,36800-13,545-13,54500-8,323-8,323-7,311-7,311-7,311-9-4,862-4,862-4,862-19-1900-62000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
507,174
510,077
512,371
514,633
517,981
521,761
525,679
621,710
641,016
645,396
651,067
655,106
639,609
652,909
661,798
670,544
675,489
679,761
686,193
690,619
695,854
736,730
744,243
754,585
763,364
774,714
866,206
865,520
876,641
893,829
898,559
905,891
930,383
832,140
749,000
737,900
1,227,600
1,244,700
1,264,300
1,248,300
1,149,600
1,179,900
1,207,900
995,500
1,011,200
1,022,400
1,040,600
1,047,300
1,070,700
0
0
001,070,7001,047,3001,040,6001,022,4001,011,200995,5001,207,9001,179,9001,149,6001,248,3001,264,3001,244,7001,227,600737,900749,000832,140930,383905,891898,559893,829876,641865,520866,206774,714763,364754,585744,243736,730695,854690,619686,193679,761675,489670,544661,798652,909639,609655,106651,067645,396641,016621,710525,679521,761517,981514,633512,371510,077507,1740000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
1,847
0
0
3,833
4,290
5,387
240,627
241,044
255,137
256,375
257,909
259,017
260,938
285,423
286,734
315,230
396,254
384,631
394,835
396,459
468,407
453,435
507,174
510,077
535,304
514,633
517,981
521,761
553,606
621,710
641,016
645,396
685,529
655,106
639,609
652,909
684,714
670,544
675,489
679,294
686,539
690,365
695,611
736,343
744,517
754,928
763,835
774,591
917,292
865,984
876,255
893,377
898,654
905,806
930,554
832,488
749,000
737,900
1,227,600
1,244,700
1,264,300
1,248,300
1,149,600
1,179,900
1,207,900
995,500
1,011,200
1,022,400
1,040,600
1,047,300
1,070,700
1,081,100
1,102,600
1,102,6001,081,1001,070,7001,047,3001,040,6001,022,4001,011,200995,5001,207,9001,179,9001,149,6001,248,3001,264,3001,244,7001,227,600737,900749,000832,488930,554905,806898,654893,377876,255865,984917,292774,591763,835754,928744,517736,343695,611690,365686,539679,294675,489670,544684,714652,909639,609655,106685,529645,396641,016621,710553,606521,761517,981514,633535,304510,077507,174453,435468,407396,459394,835384,631396,254315,230286,734285,423260,938259,017257,909256,375255,137241,044240,6275,3874,2903,833001,847000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,697,100
Cost of Revenue-537,200
Gross Profit1,159,9001,159,900
 
Operating Income (+$)
Gross Profit1,159,900
Operating Expense-939,900
Operating Income220,000220,000
 
Operating Expense (+$)
Research Development205,000
Selling General Administrative666,400
Selling And Marketing Expenses0
Operating Expense939,900871,400
 
Net Interest Income (+$)
Interest Income28,900
Interest Expense-36,200
Other Finance Cost-2,500
Net Interest Income-9,800
 
Pretax Income (+$)
Operating Income220,000
Net Interest Income-9,800
Other Non-Operating Income Expenses0
Income Before Tax (EBT)214,600225,400
EBIT - interestExpense = 111,000
198,000
242,500
Interest Expense36,200
Earnings Before Interest and Taxes (EBIT)147,200250,800
Earnings Before Interest and Taxes (EBITDA)220,000
 
After tax Income (+$)
Income Before Tax214,600
Tax Provision-9,100
Net Income From Continuing Ops120,000205,500
Net Income206,300
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,477,100
Total Other Income/Expenses Net-5,4009,800
 

Technical Analysis of Insulet
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Insulet. The general trend of Insulet is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Insulet's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Insulet Corporation.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 161.68 < 162.05 < 184.85.

The bearish price targets are: 160.84 > 160.38 > 148.22.

Tweet this
Insulet Corporation Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Insulet Corporation. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Insulet Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Insulet Corporation. The current macd is -0.06935654.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Insulet price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Insulet. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Insulet price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Insulet Corporation Daily Moving Average Convergence/Divergence (MACD) ChartInsulet Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Insulet Corporation. The current adx is 20.26.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Insulet shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Insulet Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Insulet Corporation. The current sar is 193.30.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Insulet Corporation Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Insulet Corporation. The current rsi is 39.86. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Insulet Corporation Daily Relative Strength Index (RSI) ChartInsulet Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Insulet Corporation. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Insulet price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Insulet Corporation Daily Stochastic Oscillator ChartInsulet Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Insulet Corporation. The current cci is -99.93886486.

Insulet Corporation Daily Commodity Channel Index (CCI) ChartInsulet Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Insulet Corporation. The current cmo is -28.88445401.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Insulet Corporation Daily Chande Momentum Oscillator (CMO) ChartInsulet Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Insulet Corporation. The current willr is -97.61112791.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Insulet Corporation Daily Williams %R ChartInsulet Corporation Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Insulet Corporation.

Insulet Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Insulet Corporation. The current atr is 7.70729104.

Insulet Corporation Daily Average True Range (ATR) ChartInsulet Corporation Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Insulet Corporation. The current obv is 7,451,659.

Insulet Corporation Daily On-Balance Volume (OBV) ChartInsulet Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Insulet Corporation. The current mfi is 37.55.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Insulet Corporation Daily Money Flow Index (MFI) ChartInsulet Corporation Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Insulet Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-05-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-05-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Insulet Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Insulet Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.858
Ma 20Greater thanMa 50170.014
Ma 50Greater thanMa 100170.314
Ma 100Greater thanMa 200183.918
OpenGreater thanClose166.000
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Insulet with someone you think should read this too:
  • Are you bullish or bearish on Insulet? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Insulet? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Insulet Corporation

I send you an email if I find something interesting about Insulet Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about Insulet Corporation.

Receive notifications about Insulet Corporation in your mailbox!